Myleus, incubated at Habitat, is in the list of 50 outstanding startups in Latin America. The World Economic Forum (WEF) ...
Por: Biominas Brasil / 06 Mar 2018
When we talk about the current situation in Brazil it is almost impossible to stop thinking about the words crisis, corr ...
Por: Biominas Brasil / 03 Jul 2017
The Brazilian Senate recently approved the Senate Bill PLS 200/2015, that aims to accelerate the approval and release of ...
Por: Biominas Brasil / 06 Apr 2017
I received last week a great study published in January/2017 by KPMG entitled “Pharma Outlook 2030: From evolution to
Por: Biominas Brasil / 06 Apr 2017
New legislation in Brazil aims to create a balance between using genetic resources for scientific advancement and spread ...
Por: Biominas Brasil / 14 Oct 2016
WHO WILL YOU MEET AT BIO LATIN AMERICA? Hundreds of decision-makers from the top multinational, U.S. and Latin Am ...
Por: Biominas Brasil / 31 Aug 2016
Get deeper insight into the Latin American market Expert led panel discussions will increase your understanding of, and
Por: Biominas Brasil / 10 Aug 2016
By Laura Lunardi, Technical Analyst of Biominas Brasil Recently, the Department of Science, Technology and Strategic Inp ...
Por: Biominas Brasil / 08 Aug 2016
Presenting is the perfect chance to increase your visibility and attract more partners at the 2016 BIO Latin America Con ...
Por: Biominas Brasil / 07 Aug 2016
Exciting things ahead Meet the advisory committee for the BIO Latin America 2016 Conference! We are working hard
Por: Biominas Brasil / 29 Jul 2016
PSI Immunology is a Platform of Immunological Solutions to develop products and processes to replace or reduce the use o ...
Por: Biominas Brasil / 29 Jun 2016
Although it does not seem, Brazil has always had a prominent position in drug development. Several drug development stag ...
Por: Biominas Brasil / 18 May 2016